0.012580
0.000000
0.000000
0.000000
0.010279
0.000000
0.000000
0.000000
0.019736
0.00000
0.00000
0.00000
Ory, J.
Kane, C.D.
Simpson, M.
Banaszak, L.J.
Bernlohr, D.A.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
8
90.00
90.00
90.00
79.490
97.290
50.670
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O4 S
153.157
n
3-SULFINOALANINE
S-CYSTEINESULFINIC ACID; S-SULFINOCYSTEINE
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
272
9793
9801
10.1074/jbc.272.15.9793
9092513
Biochemical and crystallographic analyses of a portal mutant of the adipocyte lipid-binding protein.
1997
10.2210/pdb1acd/pdb
pdb_00001acd
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
298
1
AREA DETECTOR
1994-04-22
SIEMENS
GRAPHITE(002)
M
x-ray
1
1.5418
1.0
1.5418
ROTATING ANODE
RIGAKU RUH2R
14532.526
ADIPOCYTE LIPID BINDING PROTEIN
C1G, V32D, F57H
1
man
polymer
ALBP
no
yes
GDAFVGTWKLVSSENFDDYMKEVGVGFATRKDAGMAKPNMIISVNGDLVTIRSESTHKNTEISFKLGVEFDEITADDRKV
KSIITLDGGALVQVQKWDGKSTTIKRKRDGDKLVVE(CSD)VMKGVTSTRVYERA
GDAFVGTWKLVSSENFDDYMKEVGVGFATRKDAGMAKPNMIISVNGDLVTIRSESTHKNTEISFKLGVEFDEITADDRKV
KSIITLDGGALVQVQKWDGKSTTIKRKRDGDKLVVECVMKGVTSTRVYERA
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
house mouse
Mus
Escherichia
sample
ADIPOCYTE
10090
Mus musculus
562
Escherichia coli
1
3.4
64.4
6.4
2.4M PHOSPHATE, PH 6.4
database_2
pdbx_database_status
struct_conn
struct_ref_seq_dif
pdbx_initial_refinement_model
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
Refinement description
1
0
1997-06-16
1
1
2008-03-24
1
2
2011-07-13
1
3
2021-11-03
1
4
2023-08-02
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_struct_conn.pdbx_leaving_atom_flag
_struct_conn.ptnr1_auth_comp_id
_struct_conn.ptnr1_auth_seq_id
_struct_conn.ptnr1_label_atom_id
_struct_conn.ptnr1_label_comp_id
_struct_conn.ptnr1_label_seq_id
_struct_conn.ptnr2_auth_comp_id
_struct_conn.ptnr2_auth_seq_id
_struct_conn.ptnr2_label_atom_id
_struct_conn.ptnr2_label_comp_id
_struct_conn.ptnr2_label_seq_id
_struct_ref_seq_dif.details
Y
BNL
1997-02-06
REL
REL
1LIB
PDB ENTRY 1LIB
PDB
experimental model
GLY
1
n
1
GLY
1
A
ASP
2
n
2
ASP
2
A
ALA
3
n
3
ALA
3
A
PHE
4
n
4
PHE
4
A
VAL
5
n
5
VAL
5
A
GLY
6
n
6
GLY
6
A
THR
7
n
7
THR
7
A
TRP
8
n
8
TRP
8
A
LYS
9
n
9
LYS
9
A
LEU
10
n
10
LEU
10
A
VAL
11
n
11
VAL
11
A
SER
12
n
12
SER
12
A
SER
13
n
13
SER
13
A
GLU
14
n
14
GLU
14
A
ASN
15
n
15
ASN
15
A
PHE
16
n
16
PHE
16
A
ASP
17
n
17
ASP
17
A
ASP
18
n
18
ASP
18
A
TYR
19
n
19
TYR
19
A
MET
20
n
20
MET
20
A
LYS
21
n
21
LYS
21
A
GLU
22
n
22
GLU
22
A
VAL
23
n
23
VAL
23
A
GLY
24
n
24
GLY
24
A
VAL
25
n
25
VAL
25
A
GLY
26
n
26
GLY
26
A
PHE
27
n
27
PHE
27
A
ALA
28
n
28
ALA
28
A
THR
29
n
29
THR
29
A
ARG
30
n
30
ARG
30
A
LYS
31
n
31
LYS
31
A
ASP
32
n
32
ASP
32
A
ALA
33
n
33
ALA
33
A
GLY
34
n
34
GLY
34
A
MET
35
n
35
MET
35
A
ALA
36
n
36
ALA
36
A
LYS
37
n
37
LYS
37
A
PRO
38
n
38
PRO
38
A
ASN
39
n
39
ASN
39
A
MET
40
n
40
MET
40
A
ILE
41
n
41
ILE
41
A
ILE
42
n
42
ILE
42
A
SER
43
n
43
SER
43
A
VAL
44
n
44
VAL
44
A
ASN
45
n
45
ASN
45
A
GLY
46
n
46
GLY
46
A
ASP
47
n
47
ASP
47
A
LEU
48
n
48
LEU
48
A
VAL
49
n
49
VAL
49
A
THR
50
n
50
THR
50
A
ILE
51
n
51
ILE
51
A
ARG
52
n
52
ARG
52
A
SER
53
n
53
SER
53
A
GLU
54
n
54
GLU
54
A
SER
55
n
55
SER
55
A
THR
56
n
56
THR
56
A
HIS
57
n
57
HIS
57
A
LYS
58
n
58
LYS
58
A
ASN
59
n
59
ASN
59
A
THR
60
n
60
THR
60
A
GLU
61
n
61
GLU
61
A
ILE
62
n
62
ILE
62
A
SER
63
n
63
SER
63
A
PHE
64
n
64
PHE
64
A
LYS
65
n
65
LYS
65
A
LEU
66
n
66
LEU
66
A
GLY
67
n
67
GLY
67
A
VAL
68
n
68
VAL
68
A
GLU
69
n
69
GLU
69
A
PHE
70
n
70
PHE
70
A
ASP
71
n
71
ASP
71
A
GLU
72
n
72
GLU
72
A
ILE
73
n
73
ILE
73
A
THR
74
n
74
THR
74
A
ALA
75
n
75
ALA
75
A
ASP
76
n
76
ASP
76
A
ASP
77
n
77
ASP
77
A
ARG
78
n
78
ARG
78
A
LYS
79
n
79
LYS
79
A
VAL
80
n
80
VAL
80
A
LYS
81
n
81
LYS
81
A
SER
82
n
82
SER
82
A
ILE
83
n
83
ILE
83
A
ILE
84
n
84
ILE
84
A
THR
85
n
85
THR
85
A
LEU
86
n
86
LEU
86
A
ASP
87
n
87
ASP
87
A
GLY
88
n
88
GLY
88
A
GLY
89
n
89
GLY
89
A
ALA
90
n
90
ALA
90
A
LEU
91
n
91
LEU
91
A
VAL
92
n
92
VAL
92
A
GLN
93
n
93
GLN
93
A
VAL
94
n
94
VAL
94
A
GLN
95
n
95
GLN
95
A
LYS
96
n
96
LYS
96
A
TRP
97
n
97
TRP
97
A
ASP
98
n
98
ASP
98
A
GLY
99
n
99
GLY
99
A
LYS
100
n
100
LYS
100
A
SER
101
n
101
SER
101
A
THR
102
n
102
THR
102
A
THR
103
n
103
THR
103
A
ILE
104
n
104
ILE
104
A
LYS
105
n
105
LYS
105
A
ARG
106
n
106
ARG
106
A
LYS
107
n
107
LYS
107
A
ARG
108
n
108
ARG
108
A
ASP
109
n
109
ASP
109
A
GLY
110
n
110
GLY
110
A
ASP
111
n
111
ASP
111
A
LYS
112
n
112
LYS
112
A
LEU
113
n
113
LEU
113
A
VAL
114
n
114
VAL
114
A
VAL
115
n
115
VAL
115
A
GLU
116
n
116
GLU
116
A
CSD
117
n
117
CSD
117
A
VAL
118
n
118
VAL
118
A
MET
119
n
119
MET
119
A
LYS
120
n
120
LYS
120
A
GLY
121
n
121
GLY
121
A
VAL
122
n
122
VAL
122
A
THR
123
n
123
THR
123
A
SER
124
n
124
SER
124
A
THR
125
n
125
THR
125
A
ARG
126
n
126
ARG
126
A
VAL
127
n
127
VAL
127
A
TYR
128
n
128
TYR
128
A
GLU
129
n
129
GLU
129
A
ARG
130
n
130
ARG
130
A
ALA
131
n
131
ALA
131
A
author_defined_assembly
2
dimeric
A
CSD
117
3-SULFINOALANINE
A
CSD
117
CYS
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
3_653
-x+1,y,-z-3/2
crystal symmetry operation
79.4900000000
0.0000000000
-76.0050000000
A
O
THR
60
A
O
THR
60
A
N
SER
53
A
N
SER
53
A
O
LEU
48
A
O
LEU
48
A
N
ASN
45
A
N
ASN
45
A
O
MET
40
A
O
MET
40
A
N
TRP
8
A
N
TRP
8
A
O
LYS
9
A
O
LYS
9
A
N
GLU
129
A
N
GLU
129
A
O
ARG
126
A
O
ARG
126
A
N
VAL
115
A
N
VAL
115
A
O
LYS
112
A
O
LYS
112
A
N
ASP
109
A
N
ASP
109
A
O
LYS
100
A
O
LYS
100
A
N
TRP
97
A
N
TRP
97
A
O
ALA
90
A
O
ALA
90
A
N
ASP
87
A
N
ASP
87
A
O
VAL
80
A
O
VAL
80
A
N
GLU
72
A
N
GLU
72
1
A
CG
LYS
9
A
CG
LYS
9
0
Y
1
A
CD
LYS
9
A
CD
LYS
9
0
Y
1
A
CE
LYS
9
A
CE
LYS
9
0
Y
1
A
NZ
LYS
9
A
NZ
LYS
9
0
Y
1
A
NZ
LYS
21
A
NZ
LYS
21
0
Y
1
A
CB
MET
35
A
CB
MET
35
0
Y
1
A
CG
MET
35
A
CG
MET
35
0
Y
1
A
SD
MET
35
A
SD
MET
35
0
Y
1
A
CE
MET
35
A
CE
MET
35
0
Y
1
A
CB
HIS
57
A
CB
HIS
57
0
Y
1
A
CG
HIS
57
A
CG
HIS
57
0
Y
1
A
ND1
HIS
57
A
ND1
HIS
57
0
Y
1
A
CD2
HIS
57
A
CD2
HIS
57
0
Y
1
A
CE1
HIS
57
A
CE1
HIS
57
0
Y
1
A
NE2
HIS
57
A
NE2
HIS
57
0
Y
1
A
CE
LYS
96
A
CE
LYS
96
0
Y
1
A
NZ
LYS
96
A
NZ
LYS
96
0
Y
1
A
NZ
LYS
120
A
NZ
LYS
120
0
Y
1
A
THR
56
-63.57
13.75
1
A
HIS
57
-162.03
-55.60
1
A
GLU
61
-170.83
143.46
1
A
ASP
109
-150.62
86.80
1
A
LYS
120
28.42
81.71
PARHCSDX.PRO
TOPHCSDX.PRO
CYO.PARAM
CYO.TOPPAR
27.6
0.2760000
0.0004
0.1980000
0.1980000
2.70
30.0
514
4452
10.1
78.8
RANDOM
1000000.
0.001
1
RESTRAINED
THROUGHOUT
2.0
MOLECULAR REPLACEMENT
PDB ENTRY 1LIB
0.574
0.41
30.0
0.280
0.22
2.70
30.0
0
1017
0
0
1017
0.010
1.56
26.7
1.21
0.3250000
0.000
0.3240000
2.82
19
145
8
2.76
23.9
54.2
2.7
30.0
1ACD
26696
2.
0.0960000
1
10.4
5.0
97.2
2.70
2.86
0.99
0.4190000
2.0
57.3
model building
X-PLOR
refinement
X-PLOR
data reduction
XENGEN
data scaling
XENGEN
phasing
X-PLOR
V32D/F57H MUTANT OF MURINE ADIPOCYTE LIPID BINDING PROTEIN
1
N
N
A
PHE
16
A
PHE
16
HELX_P
A
VAL
23
A
VAL
23
1
1
8
A
PHE
27
A
PHE
27
HELX_P
A
ALA
33
A
ALA
33
1
2
7
covale
1.333
both
A
GLU
116
A
C
GLU
116
1_555
A
CSD
117
A
N
CSD
117
1_555
covale
1.332
both
A
CSD
117
A
C
CSD
117
1_555
A
VAL
118
A
N
VAL
118
1_555
FATTY ACID BINDING PROTEIN
FATTY ACID BINDING PROTEIN
FABPA_MOUSE
UNP
1
1
P04117
CDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDLVTIRSESTFKNTEISFKLGVEFDEITADDRKV
KSIITLDGGALVQVQKWDGKSTTIKRKRDGDKLVVECVMKGVTSTRVYERA
2
131
1ACD
2
131
P04117
A
1
2
131
1
VAL
engineered mutation
ASP
32
1ACD
A
P04117
UNP
32
32
1
PHE
engineered mutation
HIS
57
1ACD
A
P04117
UNP
57
57
1
CYS
modified residue
CSD
117
1ACD
A
P04117
UNP
117
117
10
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
THR
60
A
THR
60
A
PHE
64
A
PHE
64
A
LEU
48
A
LEU
48
A
GLU
54
A
GLU
54
A
ASN
39
A
ASN
39
A
ASN
45
A
ASN
45
A
GLY
6
A
GLY
6
A
GLU
14
A
GLU
14
A
THR
125
A
THR
125
A
ARG
130
A
ARG
130
A
LYS
112
A
LYS
112
A
GLU
116
A
GLU
116
A
LYS
100
A
LYS
100
A
ASP
109
A
ASP
109
A
ALA
90
A
ALA
90
A
TRP
97
A
TRP
97
A
LYS
79
A
LYS
79
A
ASP
87
A
ASP
87
A
PHE
70
A
PHE
70
A
ILE
73
A
ILE
73
MUTATED PORTAL REGION, PROPOSED SITE OF LIGAND ENTRY.
Unknown
2
A
ASP
32
A
ASP
32
2
1_555
A
HIS
57
A
HIS
57
2
1_555
20
C 2 2 21